Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

What Is NAD+, Ketamine Wellness Center’s New Therapy?

Delic Holdings Corp.’s (OTCQB: DELCF) subsidiary Ketamine Wellness Centers will start offering a new therapy in some of its locations: NAD+ infusion therapy.

Delic Holdings Corp.’s (OTCQB:DELCF) subsidiary Ketamine Wellness Centers will start offering a new therapy in some of its locations: NAD+ infusion therapy.

Starting on May 9, the clinics in Jacksonville, Houston, Salt Lake City, Dallas, Las Vegas and Tucson will introduce the new therapy to their offerings.

NAD+ is a fundamental coenzyme found in every cell of the body thought to have multiple beneficial effects, especially in maintaining cell health. The problem is that with age NAD+ levels naturally decrease.

Currently, there are numerous brands that sell the molecule as a supplement, such as Tru Niagen, Bulletproof, Theagehack and UltraNMN, but the offering for intravenous or intramuscular administration is much lower.

 “The introduction of NAD+ infusion therapy to our clinics is a strong complement to ketamine therapy and has benefits for their mental and physical well-being,” commented Kevin Nicholson, CEO of Delic and KWC.

Total
0
Shares